Background
Adolescence is a critical period for the onset of mental illness. A partnership of a health and care network and filmmakers developed an interactive film for youth wellbeing. While such films have potential as a cost-effective preventative tool, their effectiveness remains unproven. This study aimed to assess the feasibility and acceptability of a randomised controlled trial of the interactive film intervention to improve wellbeing in school-aged youth.
Methods
In a mixed-methods cluster randomised feasibility trial in North East England (2021-2022), students in Years 10 (14-15 years) and 12 (16-17 years) from three schools were recruited and randomised to the following conditions: 1) watching the film in class, 2) watching the film in class with support from youth workers or 3) regular class activities. Feasibility outcomes included willingness of schools to participate, participant recruitment, and retention, which was accessed quantitatively and qualitatively. Data were analysed descriptively and with the use of thematic analysis.
Results
School recruitment targets were met, although this was challenging due to resource constraints and the COVID-19 pandemic. Questionnaires were completed before watching the film by 172 students (48% of the recruitment target). Follow-up targets for retention were met at 3-months (n=138) and 6-months (n=136). Retention of Year 10 students was high (96%), but Year 12 students had lower retention (60%). Qualitative findings showed students and teachers supported the intervention and trial and measurements however, consent-taking required more time. Communication and resource issues within schools were challenging and need addressing before moving to a larger trial.
Conclusion
Although some trial aspects were feasible and acceptable, particularly the intervention, others, such as recruitment, retention and school communication, posed challenges. We recommend future feasibility studies should address barriers such as randomisation, communication with schools, recruitment of older students (16-18 years), consent and measurement alignment before moving to a larger-scale trial.